Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | - | - |
Min SIP Amount | ₹100 | ₹500 |
Expense Ratio | 2.43 | 2.02 |
NAV | ₹13.79 | ₹404.61 |
Fund Started | 17 Feb 2023 | 01 Aug 2005 |
Fund Size | ₹591.73 Cr | ₹2862.87 Cr |
Exit Load | Exit load of 1%, if redeemed within 1 year. | Exit load of 1% if redeemed less than 1 year |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | -7.69% | -3.55% |
3 Year | - | 12.45% |
5 Year | - | 14.92% |
1 Year
3 Year
5 Year
Equity | 97.17% | 96.64% |
Cash | 2.83% | 2.95% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
---|---|
Maruti Suzuki India Ltd. | 7.34% |
Fortis Healthcare Ltd. | 7.27% |
United Spirits Ltd. | 7.22% |
Ambuja Cements Ltd. | 6.82% |
Lupin Ltd. | 6.63% |
Escorts Kubota Ltd. | 6.58% |
Nestle India Ltd. | 5.67% |
Cummins India Ltd. | 5.09% |
Hindustan Unilever Ltd. | 4.45% |
Anthem Biosciences Ltd. | 4.19% |
Name | Assets |
---|---|
Maruti Suzuki India Ltd. | 10.24% |
Procter & Gamble Health Ltd. | 5.36% |
Nestle India Ltd. | 5.20% |
Hindustan Unilever Ltd. | 4.63% |
Vedanta Ltd. | 3.79% |
United Spirits Ltd. | 3.60% |
Britannia Industries Ltd. | 3.46% |
3M India Ltd. | 2.90% |
Infosys Ltd. | 2.82% |
Gland Pharma Ltd. | 2.78% |
Name | Dhruv Muchhal | Karthikraj Lakshmanan |
Start Date | 14 Sep 2023 | 16 Nov 2022 |
Name
Start Date
Description | The scheme seeks to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of multinational companies (MNCs). | The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of multinational companies. |
Launch Date | 17 Feb 2023 | 01 Aug 2005 |
Description
Launch Date